Loading clinical trials...
Loading clinical trials...
Thelin (Sitaxentan Sodium) Patient Safety Registry A Non-Interventional, Patient Registry For The Collection Of Pre-Defined Safety Data In Patients Prescribed Thelin
Conditions
Interventions
Sitaxentan sodium
Locations
4
Belgium
Pfizer Investigational Site
Brussels, Belgium
Pfizer Investigational Site
Leuven, Belgium
Pfizer Investigational Site
Nice, France
Pfizer Investigational Site
Hanover, Germany
Start Date
April 1, 2010
Primary Completion Date
February 1, 2011
Completion Date
February 1, 2011
Last Updated
February 7, 2012
NCT07218029
NCT06649110
NCT06481852
NCT01347216
NCT05464095
NCT06954727
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions